Increased transforming growth factor β1 plasma level in patients with renal cell carcinoma: A tumor-specific marker?

Urologia Internationalis

Volumn 60, Issue 4, 1998, Pages 205-207

  Wunderlich, H ^a   Steiner, T ^a   Kosmehl, H ^a   Junker, U ^a   Reinhold, D ^b   Reichelt, O ^a   Zermann, D H ^a   Schubert, J ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Plasma level; Pyelonephritis; Renal cell carcinoma; TGF 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKER;

ARTICLE; BLOOD SAMPLING; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACORPOREAL LITHOTRIPSY; HUMAN; HUMAN TISSUE; INFLAMMATION; KIDNEY CARCINOMA; METASTASIS; NEPHRECTOMY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PYELONEPHRITIS;

CARCINOMA, RENAL CELL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; KIDNEY NEOPLASMS; LITHOTRIPSY; PYELONEPHRITIS; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKERS, BIOLOGICAL;

EID: 0031708258     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030255     Document Type: Article

References (10)

1. Phillips AO, Steadman R, Topley N, Williams JD: Elevated D-glucose concentration modulates TGF-beta 1 synthesis by human cultured renal proximal tubular cells: The permissive role of platelet-derived growth factor. Am J Pathol 1995;147:362.
2. Lawrence DA: Transforming growth factor-β: An overview. Kidney Int 1995;47:19.
3. Cerwenka A, Bevec D, Majdic O, Knapp W, Holler W: TGF-β1 is a potent inducer of human effector T cells. J Immunol 1994;153: 4367.
4. Barnard JA, Lyons RM, Moses HM. The cell biology of transforming growth factor beta. Biochim Biophys Acta 1990;1032:79.
5. Reinhold D, Bank U, Bühling F, Lendeckel U, Ulmer AJ, Flad H-D, Ansorge S: Transforming growth factor-β1 (TGF-β1) inhibits DNA synthesis of PWM-stimulated PBMC via suppression of IL-2 and IL-6 production. Cytokine 1994;6:382.
6. Reinhold D, Bank U, BüWing F, Lendeckel, Ansorge S: Transforming growth factor-β1 inhibits interleukin-10 mRNA expression and production in pokeweed mitogen-stimulated peripheral blood mononuclear cells and T cells. J Interferon Cytokine Res 1995;15:685.
7. Knoefel B, Junker U, Nuske K, El-Seweifi A, Junker K, Kosmehl H, Jäger L: Untersuchungen von Primärkulturen verschiedener Nierenzellkarzinome in Hinblick auf immunmodulatorische Effekte. Immun Infekt 1995;23:72.
8. Danielpour D: Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor beta-1. J Immunol Methods 1993;158:17.
9. Grainger DJ, Mosedale DE, Metcalfe JC, Weissberg PL, Kemp PR: Active and acid-activatable TGF-beta in human sera, platelets and plasma. Clin Chim Acta 1995;235:11.
10. Beck J, Rondot P, Juillien P, Wietzerbin J, Lawrence DA: TGF-β-like activity produced during regression of exacerbations in multiple sclerosis. Acta Neurol Scand 1991;84:452.